Healthy Skepticism Library item: 1237

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Bozik M.
He who pays the piper calls the tune: the role of the industry sponsor in acute stroke trials.
Eur Neurol 2003; 49:(2):128-30
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=ENE49128

Abstract:

Ischemic stroke remains a complex neurobiological and clinical disease, and stroke drug development remains time consuming and costly. In addressing these challenges, the pharmaceutical industry has a principal responsibility to ensure that the acute stroke trials it sponsors are ethically conducted, scientifically sound and satisfy global regulatory requirements. The industry must also be a leader in promoting the innovative and effective partnerships between the public, private and academic sectors that are necessary if new therapies for patients with acute stroke are to be developed.

Keywords:
Acute Disease Cerebrovascular Accident/drug therapy* Clinical Trials/ethics* Clinical Trials/standards* Drug Industry/standards* Humans